title: Biological properties of melanoma and endothelial cells after plasmid AMEP gene electrotransfer depend on integrin quantity on cells.
abstract: The data on the biological responsiveness of melanoma and endothelial cells that are targeted by Antiangiogenic MEtargidin Peptide (AMEP) are limited; therefore, the antiproliferative, antimetastatic and antiangiogenic effects of AMEP were investigated in murine melanoma and human endothelial cells after plasmid AMEP gene electrotransfer into the cells in vitro. Plasmid AMEP, a plasmid coding for the disintegrin domain of metargidin targeting specific integrins, had cytotoxic and antiproliferative effects on murine melanoma and human endothelial cells. Among the metastatic properties of cells, migration, invasion and adhesion were investigated. Plasmid AMEP strongly affected the migration of murine melanoma and human endothelial cell lines and also affected the invasion of highly metastatic murine melanoma B16F10 and human endothelial cell lines. There was no effect on cell adhesion on Matrigel(TM) or fibronectin in all cell lines. The antiangiogenic effect was shown with tube formation assay, where human microvascular endothelial cell line (HMEC-1) proved to be more sensitive to plasmid AMEP gene electrotransfer than the human umbilical vein endothelial cell line (HUVEC). The study indicates that antiproliferative and antimetastatic biological responses to gene electrotransfer of plasmid AMEP in murine melanoma cells were dependent on the integrin quantity on melanoma cells and not on the expression level of AMEP. The strong antiangiogenic effect expressed in human endothelial cell lines was only partly dependent on the quantity of integrins and seemed to be plasmid AMEP dose dependent.
authors: Department of Experimental Oncology, Institute of Oncology Ljubljana, Zaloska 2, 1000, Ljubljana, Slovenia.
authors: Masa
authors: M
authors: Bosnjak
authors: Lara
authors: L
authors: Prosen
authors: Tanja
authors: T
authors: Dolinsek
authors: Tanja
authors: T
authors: Blagus
authors: Bostjan
authors: B
authors: Markelc
authors: Maja
authors: M
authors: Cemazar
authors: Celine
authors: C
authors: Bouquet
authors: Gregor
authors: G
authors: Sersa
mesh_terms: D000818:Animals; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D002470:Cell Survival; D018274:Electroporation; D061307:Human Umbilical Vein Endothelial Cells / Q000378:metabolism*; D006801:Humans; D039081:Integrin alpha5beta1 / Q000378:metabolism*; D039302:Integrin alphaVbeta3 / Q000378:metabolism*; D016023:Integrins / Q000378:metabolism*; D008546:Melanoma, Experimental; D051379:Mice; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic / Q000378:metabolism; D010957:Plasmids / Q000235:genetics; D014162:Transfection
chemical_list: D039081:Integrin alpha5beta1; D039302:Integrin alphaVbeta3; D016023:Integrins
references: Cancer Res. 2004 Mar 15;64(6):2062-9
references: 15026344
references: Proc Soc Exp Biol Med. 1999 Nov;222(2):124-38
references: 10564536
references: Radiol Oncol. 2012 Dec;46(4):302-11
references: 23412658
references: Cancer Metastasis Rev. 2005 Jun;24(2):195-222
references: 15986132
references: Methods Mol Biol. 2008;423:351-9
references: 18370213
references: Nat Rev Cancer. 2008 Aug;8(8):604-17
references: 18497750
references: J Cell Sci. 1999 Feb;112 ( Pt 4):579-87
references: 9914169
references: Cancer Res. 1990 Oct 15;50(20):6757-64
references: 2208139
references: IEEE Trans Med Imaging. 2005 Apr;24(4):549-53
references: 15822812
references: Curr Gene Ther. 2010 Aug;10(4):300-11
references: 20560875
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: Int J Clin Oncol. 2006 Jun;11(3):176-83
references: 16850123
references: Mol Pharm. 2012 Nov 5;9(11):2961-73
references: 22967287
references: Retina. 2005 Feb-Mar;25(2):111-8
references: 15689799
references: Eur J Surg Oncol. 2013 Jan;39(1):4-16
references: 22980492
references: Breast Cancer Res Treat. 2012 Aug;134(3):1169-78
references: 22821399
references: Hum Pathol. 1999 May;30(5):562-7
references: 10333228
references: Eur J Surg Oncol. 2008 Feb;34(2):232-40
references: 17614247
references: J Membr Biol. 2012 Sep;245(9):545-54
references: 22644389
references: Radiol Oncol. 2012 Dec;46(4):271-8
references: 23412694
references: Dermatol Ther. 2010 Nov-Dec;23(6):651-61
references: 21054709
references: J Biol Chem. 1998 Mar 27;273(13):7345-50
references: 9516430
references: Eur J Pharm Biopharm. 2011 Aug;78(3):314-9
references: 21316447
references: Med Biol Eng Comput. 2012 Dec;50(12):1213-25
references: 23179413
references: Curr Opin Cell Biol. 1996 Oct;8(5):724-30
references: 8939661
references: BMC Cancer. 2004 Nov 16;4:81
references: 15546484
references: Nat Rev Cancer. 2010 Jan;10(1):9-22
references: 20029421
references: Science. 1994 Apr 22;264(5158):569-71
references: 7512751
references: J Clin Oncol. 2008 Dec 20;26(36):5896-903
references: 19029422